Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
07/05/1992 | WO1992012169A1 Pseudomonas peptide composition and method for producing the same |
07/05/1992 | CA2094938A1 Dna sequences related to isolated fragile x syndrome |
07/03/1992 | WO1992012237A1 Fusions of a viral protein and a destructive enzyme |
07/01/1992 | EP0492964A2 Cloning and expression of Borrelia lipoproteins |
07/01/1992 | EP0492920A1 Chimaeric influenza-HIV vaccine |
07/01/1992 | EP0492614A2 Epitheliocyte growth accelerator |
07/01/1992 | EP0492560A2 Human monoclonal antibodies directed against the transmembrane glycoprotein (gp41) of HIV-1, and related peptides |
07/01/1992 | EP0492552A1 Anti-IGF-II monoclonal antibody |
07/01/1992 | EP0492530A1 Monoclonal antibodies which bind mannose binding protein |
07/01/1992 | EP0492525A2 Babesial protease antigen |
07/01/1992 | EP0492500A2 Protecting plasmodium falciparum hybrid proteins, containing partial sequences of malaria antigens HRPII and SERP |
07/01/1992 | EP0492448A1 Monoclonal antibodies against human tumor necrosis factor alpha |
07/01/1992 | EP0492274A2 An asporogenous strain of bacillus subtilis and its use as a host for the preparation of heterologous products |
07/01/1992 | EP0492214A2 Human Interleukin-5 receptor |
07/01/1992 | EP0492179A2 Avian growth hormone receptor and binding protein |
07/01/1992 | EP0491888A1 Immunotherapeutic compositions for treating and preventing aids, arc and hiv infection |
07/01/1992 | EP0491867A1 Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer. |
07/01/1992 | EP0491859A1 TREPONEMA HYODYSENTERIAE ANTIGENS HAVING A MOLECULAR WEIGHT OF 39kDa AND DNA ENCODING THEREFOR |
07/01/1992 | EP0491849A1 A method for the purification of transforming growth factor (tgf-). |
06/30/1992 | US5126434 Monoclonal antibody specific for a human macrophage chemotactic factor |
06/30/1992 | US5126323 Homogeneous purified k-fgf and compositions containing the same |
06/30/1992 | US5126322 Pancreatic secretory tryspin inhibitor and variants thereof produced by a recombinant host therefore and pharmaceutical use thereof |
06/30/1992 | US5126253 Production of monoclonal antibodies |
06/30/1992 | US5126250 Alteration of carboxy-terminal amino acid or acids from one or both of antibody heavy chains |
06/30/1992 | US5126249 Enzymatic removal of a protein amino-terminal sequence |
06/30/1992 | US5126240 Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
06/30/1992 | US5126148 Produced by human hematopoietic cells |
06/30/1992 | US5126130 Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a |
06/30/1992 | CA1304305C Monoclonal antibody, and its preparation and use |
06/30/1992 | CA1304288C Cell-free t cell antigen receptor and its clinical utilities |
06/29/1992 | WO1992012177A1 Novel megakaryocyte amplifier and production thereof |
06/29/1992 | CA2073177A1 Megakaryocyte potentiator and method for producing the same |
06/29/1992 | CA2058351A1 Avian growth hormone receptor and binding protein |
06/28/1992 | CA2058003A1 Human-interleukin-5 receptor |
06/25/1992 | WO1992010755A1 Proteins with changed epitopes and methods for the production thereof |
06/25/1992 | WO1992010583A1 G protein-coupled glutamate receptors |
06/25/1992 | WO1992010578A1 Dna expression systems based on alphaviruses |
06/25/1992 | WO1992010569A1 Sperm cell surface protein ph-20. use in a contraceptive vaccine |
06/25/1992 | WO1992010567A1 Synthetic bioadhesive polypeptide |
06/25/1992 | WO1992010520A1 Monoclonal antibody op-g2 and method of use |
06/25/1992 | WO1992010519A1 A novel protein tyrosine kinase |
06/25/1992 | WO1992010513A1 Subunit papillomavirus vaccine and peptides for use therein |
06/25/1992 | WO1992010511A1 Compounds and compositions which inhibit bone resorption |
06/25/1992 | WO1992010197A1 Substances of polypeptide nature useful in human therapy |
06/25/1992 | WO1992008731A3 T-cadherin adhesion molecule |
06/25/1992 | DE4041464A1 5-ht(pfeil abwaerts)1(pfeil abwaerts)-rezeptor 5-ht (Down Arrow) 1 (down arrow) receptor |
06/25/1992 | DE4041304A1 Von strukturproteinen des hepatitis c-virus abgeleitete polypeptide, testkits, die diese polypeptide enthalten und impfstoffe gegen infektionen von hepatitis c-viren Of structural proteins of the hepatitis C virus-derived polypeptides, test kits containing such polypeptides, and vaccines against infection by hepatitis C virus |
06/25/1992 | CA2614365A1 Dna expression systems based on alphaviruses |
06/25/1992 | CA2098292A1 Dna expression systems based on alphaviruses |
06/25/1992 | CA2098188A1 Sperm cell surface protein ph-20 use in a contraceptive vaccine |
06/25/1992 | CA2057963A1 Chimaeric influenza-hiv vaccine |
06/25/1992 | CA2057761A1 Protective plasmodium falciparum hybrid proteins which contain part-sequences of the malaria antigens hrpii and serp, the preparation and use thereof |
06/25/1992 | CA2057675A1 Peptide inhibitors of ras-gap interaction |
06/25/1992 | CA2056118A1 Monoclonal antibodies which bind mannose binding protein |
06/24/1992 | EP0491675A1 Improvements relating to growth factors |
06/24/1992 | EP0491351A2 Chimeric antibodies and their use |
06/24/1992 | EP0491114A1 A process for preparing new non-covalent polysaccharide-protein associations having pharmacological activity |
06/24/1992 | EP0491057A1 Hybridoma which produces avian specific immunoglobulin g |
06/24/1992 | EP0491032A1 Substance with interleukin-8 inhibiting activity and process for its preparation |
06/24/1992 | EP0490975A1 Interleukin-4 receptors |
06/24/1992 | EP0207963B1 Monoclonal antibodies and antigen for human non-small cell lung carcinomas |
06/24/1992 | CN1062172A Ribosome-inactivating proteins, inactive precursor forms thereof, process for making and method of using |
06/24/1992 | CN1062169A Pichia pastoris acid phosphatae gene |
06/23/1992 | WO1992011362A1 Serotonine receptor of class 1: the 5-ht1x receptors |
06/23/1992 | US5124440 Antibody and T cell recognition sites on glycoproteins comprising the GCI complex of human cytomegalovirus |
06/23/1992 | US5124439 Detecting, preventing, treating blood clot formation |
06/23/1992 | US5124264 Monoclonal antibody recognizing atrial natriuretic polypeptide |
06/23/1992 | US5124255 CKS method of protein synthesis |
06/23/1992 | US5124248 Medical diagnosis; immunoassay |
06/23/1992 | CA2098706A1 5-ht1x receptor |
06/23/1992 | CA1304191C Process for renaturing proteins |
06/23/1992 | CA1304026C Vector and method for achieving high level expression in eukaryotic cells |
06/23/1992 | CA1304025C Modified zein |
06/23/1992 | CA1304024C Covalently linked polypeptide cell modulators |
06/23/1992 | CA1304023C .beta.-UROGASTRONE GENE, CORRESPONDING RECOMBINANT PLASMIDS, CORRESPONDING TRANSFORMANTS AND PREPARATION THEREOF AND OF .beta.-UROGASTRONE |
06/23/1992 | CA1304022C Insulin precursors, process for their preparation and process for preparing human insulin from such insulin precursors |
06/23/1992 | CA1304021C Microbiological process for the preparation of a protein by culturing a mutant bacterial strain |
06/23/1992 | CA1304020C High level expression in yeast |
06/23/1992 | CA1303980C Monoclonal antibodies against glycolipid antigens, methods of producing these antibodies and use therefor |
06/22/1992 | WO1992011387A1 Diagnosis for porcine malignant hyperthermia |
06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
06/22/1992 | CA2079702A1 Diagnosis for porcine malignant hyperthermia |
06/22/1992 | CA2058379A1 Babesial protease antigen |
06/22/1992 | CA2058280A1 Expression systems |
06/22/1992 | CA2035809A1 Bilipeptides and processes for their preparation |
06/21/1992 | WO1992011272A1 Optimization of binding proteins |
06/21/1992 | WO1992011120A1 Method and apparatus for granulation |
06/21/1992 | CA2098824A1 Optimization of binding proteins |
06/21/1992 | CA2098600A1 Method and apparatus for granulation |
06/20/1992 | WO1992011378A1 A method of constructing synthetic leader sequences |
06/20/1992 | WO1992011018A1 Improved humanized immunoglobulins |
06/20/1992 | CA2098731A1 Method of constructing synthetic leader sequences |
06/20/1992 | CA2057715A1 Method for enhancing the structural stability of recombinant dna expression vectors |
06/19/1992 | WO1992011377A1 Tissue plasminogen activator substitution variant |
06/19/1992 | WO1992011360A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
06/19/1992 | CA2098484A1 Analogs of acidic fibroblast growth factor having enhanced stability and biological activity |
06/19/1992 | CA2057951A1 Chimeric antibodies and their use |
06/19/1992 | CA2057842A1 Human monoclonal antibody |
06/17/1992 | EP0490410A1 TXA2 Receptor and gene encoding the same |